The Association of Clinical Research Professionals

Webinar Replay—Best Practices for Communicating Benefit, Risk, and Uncertainty in Medical Device Clinical Trials

Pricing with Contact Hours

Member: $15 | Nonmember: $75

Add to Cart

This course is approved for 1.0 ACRP contact hours. Accreditation Details


Pricing without Contact Hours

Member: $0 | Nonmember: N/A

ADD TO CART


Speakers:

  • Stephanie Christopher,MA, CCRC, FACRP,  Associate Director of Research Programs, National Organization for Rare
    Disorders (NORD)
  • Liliana Rincon-Gonzalez, PhD, Program Director, Clinical Science, MDIC
  • Scott Goates, Ph.D., MBA, Senior Advisor, Health Economics and Outcomes Research, Abbott
  • Mimi Nguyen, Health Sciences Project Manager, FDA Center for Devices and Radiological Health

Effective communication is fundamental to the ethical design and conduct of clinical trials. Research participants cannot make an informed decision to participate in a clinical trial without clear communications from the research professionals supporting the trial. These evidence-based practices will help clinical research professionals in the conduct of their clinical trial activities, including patient education and informed consent. It is important for clinical research professionals to learn that effective communication is not simply parroting information to patients and hoping they understand, but deliberately engaging with patients to present information in a way they can understand and use that information to make clinical decisions.

Upon completion of this Webinar, attendees should be able to understand and identify:

  1. Define benefits, risks, uncertainty, and patient preferences regarding the use of medical technology
  2. Understand the evidence-based practices for communicating the benefits, risks, and uncertainty regarding medical technology to patients and providers
  3. Identify best methods for benefit-risk communication to patients and how such information can be most effectively developed

Webinar Replay expires December 16, 2024.